Jakavi 5mg Tablet

Jakavi 5mg Tablet contains the active ingredient Ruxolitinib and belongs to the class of kinase inhibitors. It is an anticancer medication used to treat myelofibrosis, a rare bone marrow disorder that disrupts normal blood cell production. It is also prescribed for polycythemia vera, a condition where the body produces excess red blood cells, particularly in patients with inadequate response to hydroxyurea. Additionally, Jakavi 5mg tablet is approved for GVHD (Graft versus Host Disease) in adults and children aged 12 years and above who have shown inadequate response to steroid or systemic therapies. The Jakavi 5mg dosage for myelofibrosis is determined by the treating physician based on body weight, blood counts, and treatment response. It works by blocking abnormal signalling pathways that drive excessive cell growth, helping to reduce symptoms such as spleen enlargement and fatigue. Patients should avoid this medication if allergic to Ruxolitinib or any components. Inform your doctor if you have a history of tuberculosis, hepatitis B or C, liver or kidney disease, or low blood cell counts. Common side effects include dizziness, headache, swelling, bruising, and reduced platelet levels. Notify your doctor immediately if you experience persistent bleeding or infection. Jakavi 5mg Tablet pricing in India may vary by pharmacy or region. Patients can obtain Jakavi 5mg Tablet online from verified sources to ensure authenticity. If unavailable, your doctor may recommend an alternative such as Ruxolix, though both have similar efficacy and composition. Jakavi is used in haematology for managing complex blood and bone marrow disorders.

Jakavi 5mg uses are Myelofibrosis Polycythemia vera Acute-graft-versus-host disease Chronic-graft-versus-host disease

Ruxolitinib, a kinase inhibitor, inhibits dysregulated Janus Associated Kinase (JAK) 1 and JAK2 signaling associated with myelofibrosis and polycythemia vera. By blocking certain enzymes, this medicine can reduce the serious risk of blood or vascular complications in myelofibrosis and polycythemia vera. In GvHD, it reduces the signs and symptoms, improving the disease and survival of transplanted cells.

Your doctor will decide the dose and duration of Jakavi 5mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Jakavi 5mg side effects are Common Low red and white blood cell counts Low platelet counts Dizziness, headache Bruising Diarrhea Infections, including viral infections Swelling in the face and body Fatigue or tiredness Serious Severe infections like hepatitis B Anemia Bleeding